Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Cellular Physiology
|
March 4, 2000
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2
E Haÿ, J Lemonnier, D Modrowski, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1980
[Mid-systolic click syndrome, coronary spasm and sudden death. General review apropos of a tracing from terminal Prinzmetal's angina, recorded by the Holter method]
P Delebarre, P Fouilland, E Hansen, et al.
The American Journal of Pathology
|
May 5, 2001
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1
J Lemonnier, E Haÿ, P Delannoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 9, 2001
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis
J Lemonnier, E Haÿ, P Delannoy, et al.
Experimental Cell Research
|
June 15, 2004
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway
F Debiais, G Lefèvre, J Lemonnier, et al.
The Journal of Clinical Investigation
|
April 29, 1998
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome
A Lomri, J Lemonnier, M Hott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
ESMO Open
|
May 16, 2025
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)
A-S Hamy, B Grandal, F Jochum, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Cellular Physiology
|
March 4, 2000
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2
E Haÿ, J Lemonnier, D Modrowski, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1980
[Mid-systolic click syndrome, coronary spasm and sudden death. General review apropos of a tracing from terminal Prinzmetal's angina, recorded by the Holter method]
P Delebarre, P Fouilland, E Hansen, et al.
The American Journal of Pathology
|
May 5, 2001
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1
J Lemonnier, E Haÿ, P Delannoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 9, 2001
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis
J Lemonnier, E Haÿ, P Delannoy, et al.
Experimental Cell Research
|
June 15, 2004
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway
F Debiais, G Lefèvre, J Lemonnier, et al.
The Journal of Clinical Investigation
|
April 29, 1998
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome
A Lomri, J Lemonnier, M Hott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
ESMO Open
|
May 16, 2025
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)
A-S Hamy, B Grandal, F Jochum, et al.
ESMO Open
|
April 16, 2025
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
M Saint-Ghislain, S Chabaud, F Dalenc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Page
of 3